Qiandao Fund
Overview
Qiandao Investment Fund Management Co., Ltd. is a private equity firm founded in 2011 and is a subsidiary of Qiandao Investment Holding Group. The firm focuses on equity investments in strategic emerging industries, including pharmaceuticals and healthcare, new-generation information technology, high-end manufacturing, new energy, and new materials.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Innovo Therapeutics | Dec 2023 | Seed | Co-investor |
| Beijing Daxiang Biotech Co., Ltd. | Nov 2022 | Pre Seed | Co-investor |
| MORE Health | Jun 2021 | Series D | Co-investor |
| Xiamen LP Pharmaceutical Co., Ltd. | Aug 2020 | Series C | Co-investor |
| MabPlex | Jun 2020 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Qiandao Fund based?
Qiandao Fund is headquartered in Beijing, Beijing, China.
When was Qiandao Fund founded?
Qiandao Fund was founded in 2011.
How many portfolio companies does Qiandao Fund have?
Qiandao Fund has 6 portfolio companies in Caplight's dataset.
What are some companies in Qiandao Fund's portfolio?
Recent investments visible on Caplight include Innovo Therapeutics, Beijing Daxiang Biotech Co., Ltd., MORE Health, Xiamen LP Pharmaceutical Co., Ltd., MabPlex.
What was Qiandao Fund's most recent investment?
Qiandao Fund's most recent investment on Caplight was in Innovo Therapeutics in 2023.
What sectors does Qiandao Fund focus on?
Qiandao Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Qiandao Fund focus on?
Stage focus information for Qiandao Fund is not publicly available.